Med Page Today
MAY 6, 2024
(MedPage Today) -- Higher olive oil intake was associated with a lower risk of dementia-related mortality, a prospective study of 90,000 healthcare professionals showed. Eating at least 7 g of olive oil daily -- about a half tablespoon --.
Science Daily - Stroke
MAY 6, 2024
A new study has revealed that areas of age-related damage in the brain relate to motor outcomes after a stroke -- a phenomenon that may be under-recognized in stroke research. The new observational study looked at the relationship between stroke recovery and white matter hyper-intensities (WMHs) -- areas of age-related damage in the brain's white matter, which represent vascular dysfunction and are known to impact cognitive functions.
Med Page Today
MAY 6, 2024
(MedPage Today) -- Children diagnosed with hypertension had a higher associated long-term risk of major adverse cardiac events (MACE) compared with matched controls without the condition, according to a Canadian population-based, retrospective.
HCPLive
MAY 6, 2024
In an interview, Paul Appelbaum, MD, discussed issues clinicians will need to bring up to their patients if the FDA approves a psychedelic-assisted therapy.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
DAIC
MAY 6, 2024
Getty Images milla1cf Mon, 05/06/2024 - 10:48 May 6, 2024 — Tenax Therapeutics, Inc. , a Phase 3, development-stage pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, announced that the United States Patent and Trademark Office ( USPTO ) has granted the Company a patent covering the use of TNX-103 (oral l evosimendan ), TNX-102 (subcutaneous levosimendan), TNX-101 (IV levosimendan
HCPLive
MAY 6, 2024
The final in our 3-part quiz series based on the NLA's 2024 update to their 2019 scientific statement on use of lipoprotein(a) in clinical practice focuses on treatment considerations and therapeutic options for elevated Lp(a).
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
HCPLive
MAY 6, 2024
Lykos Therapeutics' new drug application for MDMA plus psychiatric intervention for adults with PTSD will be the first reviewed by an FDA committee for such a therapy.
DAIC
MAY 6, 2024
milla1cf Mon, 05/06/2024 - 10:55 May 6, 2024 — SMT (Sahajanand Medical Technologies), a leading medical device company at the forefront of innovative patient care in the cardiovascular segment has announced a strategic partnership with HeartX , a pioneering MedTech company focused on research and development. Through this collaboration, SMT gains an innovative product line in the Congenital Heart Defect space.
Med Page Today
MAY 6, 2024
(MedPage Today) -- With some help from artificial intelligence (AI), country music star Randy Travis, celebrated for his timeless hits like "Forever and Ever, Amen" and "I Told You So," has his voice back. In July 2013, Travis was hospitalized.
Medical Xpress - Cardiology
MAY 6, 2024
New data reveal that percutaneous coronary intervention (PCI) can be safely performed before, during, or after transcatheter aortic valve replacement (TAVR) for patients with stable coronary artery disease (CAD). The results from the analysis were presented at the Society for Cardiovascular Angiography & Interventions (SCAI) 2024 Scientific Sessions.
HCPLive
MAY 6, 2024
Vitamin D concentration was significant in chronic hepatitis B virus but not hepatitis C virus infection, suggesting its potential impact on immune response.
Cardiovascular Diabetology
MAY 6, 2024
Sodium-glucose cotransporter 2 (SGLT2) and SGLT1 inhibitors may have additional beneficial metabolic effects on circulating metabolites beyond glucose regulation, which could contribute to a reduction in the b.
American College of Cardiology
MAY 6, 2024
The following are key points to remember from a European consensus statement on embolic strokes of undetermined source.
HCPLive
MAY 6, 2024
In this interview, Browning discusses his team’s trial data and the implications of the FDA’s decision to accept the supplemental new drug application for tapinarof as an eczema treatment.
American College of Cardiology
MAY 6, 2024
What is the prevalence, what is the genetic predisposition, and what are the clinical consequences of reduced left (LVEF) and/or right ventricular ejection fraction (RVEF) among endurance athletes?
Nature Reviews - Cardiology
MAY 6, 2024
Nature Reviews Cardiology, Published online: 07 May 2024; doi:10.1038/s41569-024-01014-0 In 1993, Lincoff and Topol claimed that the thrombolytic treatment of ST-segment elevation myocardial infarction was suboptimal in many patients and gave an ‘illusion of reperfusion’. In this Perspective article, the authors propose that a similar illusion of revascularization exists for contemporary percutaneous revascularization in patients with coronary artery disease and ischaemia, and identify how outco
American College of Cardiology
MAY 6, 2024
Although atrial fibrillation/atrial flutter (AFib/AFL) are common manifestations of transthyretin amyloid cardiomyopathy (ATTR-CM), a post hoc analysis of the ATTR-ACT study, published April 30 in JACC: CardioOncology, found they do not predict all-cause mortality. Furthermore, baseline or historical AFib/AFL did not impact the efficacy of treatment with tafamidis.
Cardiovascular Diabetology
MAY 6, 2024
In observational and experimental studies, diabetes has been reported as a protective factor for aortic dissection. 3-Hydroxybutyrate, a key constituent of ketone bodies, has been found to favor improvements i.
American College of Cardiology
MAY 6, 2024
Does treatment with varenicline or combined nicotine replacement therapy (CNRT) improve smoking cessation rates among smokers who do not quit on their initial attempt?
HCPLive
MAY 6, 2024
Retina specialists and an AI screening tool trained to measure geographic atrophy agreed in a majority of cases, potentially expediting clinical trial enrollment and increasing consistency in measuring the disease.
Learning + Leading
MAY 6, 2024
If you’re a healthcare human resources professional and missed this year’s fantastic ASHHRA conference in Fort Worth, TX , a few weeks ago we’ve got you covered! We know you’re searching for cutting-edge healthcare HR staffing solutions that will give you the skills insights you need to build smarter training programs. That’s why NHA was there to showcase our variety of healthcare employer staffing solutions.
HCPLive
MAY 6, 2024
The meta-analysis demonstrated gout with high blood uric acid levels significantly increases the risk of experiencing angina attacks.
American College of Cardiology
MAY 6, 2024
Dive into the Heart of ACC.24's Heart Failure and Transplant Highlights! In this podcast, Drs. Maya Guglin, Shelley Hall, Onyedika Ilonze, and Kazuhiko Kido dissect the most captivating advancements and groundbreaking revelations from the ACC.24 sessions in heart failure and transplant, including trials RELIEVE-HF, REDUCE-AMI, and DanGer Shock.
HCPLive
MAY 6, 2024
Data from the ORCA-V trial suggests cytisinicline, a plant-based medication, aids adults in quitting e-cigarettes.
Cardiovascular Diabetology
MAY 6, 2024
Given the increasing attention to glycemic variability (GV) and its potential implications for cardiovascular outcomes. This study aimed to explore the impact of acute GV on short-term outcomes in Chinese pati.
HCPLive
MAY 6, 2024
At ARVO 2024, Ashkan Abbey, MD describes key data from the pivotal OAKS and DERBY, and the GALE extension trial over 3 years of pegcetacoplan treatment.
Cardiovascular Diabetology
MAY 6, 2024
Both the triglyceride-glucose (TyG) index, as a surrogate marker of insulin resistance, and systemic inflammation are predictors of cardiovascular diseases; however, little is known about the coexposures and r.
HCPLive
MAY 6, 2024
The utility of second-generation antipsychotics and clozapine has been less advantageous than it could be, Kane explained.
Cardiovascular Diabetology
MAY 6, 2024
The association between iron biomarkers and cardiovascular disease risk factors (CVD-RFs) remains unclear. We aimed to (1) evaluate the cross-sectional and longitudinal associations between iron biomarkers (se.
HCPLive
MAY 6, 2024
The anti-VEGF agent tarcocimab significantly improved diabetic retinopathy severity score compared with SHAM in a phase 3 study.
Journal of Cardiothoracic Surgery
MAY 6, 2024
The long-term prognosis of patients with coronary artery disease (CAD) with diffuse long lesion underwent coronary artery bypass graft (CABG) or percutaneous coronary intervention (PCI) remains worse. Here, we.
HCPLive
MAY 6, 2024
In an interview, Ryan McLaughlin discussed the ethical concerns regarding treating psychiatric illness with cannabis.
Journal of Cardiothoracic Surgery
MAY 6, 2024
Injury to coronary arteries during mitral surgery is a rare but life-threatening procedural complication, an anomalous origin and course of the left circumflex artery (LCx) increase this risk. Recognizing the.
HCPLive
MAY 6, 2024
Both overall TEAEs and serious TEAEs were numerically higher in those receiving upadacitinib compared with adalimumab.
Frontiers in Cardiovascular Medicine
MAY 6, 2024
Viral myocarditis is an important cause of non-ischemic cardiomyopathy. Multiple clinical manifestations have been reported, including acute heart failure, cardiogenic shock, and ventricular arrhythmias. We present three patients with clinically suspected viral myocarditis causing acute heart failure. Serum coxsackievirus B antibodies were positive in all three patients.
HCPLive
MAY 6, 2024
BI 764524 was well tolerated following intravitreal administration of single and multiple doses in the phase 1/2a trial, with signs pointing to early efficacy.
Expert insights. Personalized for you.
145 
Let's personalize your content